Optimizing Outcomes in Patients with HER2+ Metastatic Breast Cancer: Translating Evidence to Clinical Practice - Episode 9

Novel Agents Under Evaluation for HER2+ Breast Cancer and Brain Metastases

, ,

A look at exciting clinical trials enrolling patients with HER2+ breast cancer and leptomeningeal disease, a previously unheard-of opportunity.